These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27216947)

  • 21. Vildagliptin vs liraglutide as a second-line therapy switched from sitagliptin-based regimens in patients with type 2 diabetes: A randomized, parallel-group study.
    Takeshita Y; Takamura T; Kita Y; Otoda T; Kato K; Wakakuri H; Yamada M; Misu H; Matsushima Y; Kaneko S;
    J Diabetes Investig; 2015 Mar; 6(2):192-200. PubMed ID: 25802727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial.
    Smits MM; Tonneijck L; Muskiet MH; Kramer MH; Pouwels PJ; Pieters-van den Bos IC; Hoekstra T; Diamant M; van Raalte DH; Cahen DL
    Diabetologia; 2016 Dec; 59(12):2588-2593. PubMed ID: 27627981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of add-on treatments to metformin in a Swedish setting: liraglutide vs sulphonylurea or sitagplitin.
    Steen Carlsson K; Persson U
    J Med Econ; 2014 Sep; 17(9):658-69. PubMed ID: 24950434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effectiveness of second line glucose lowering drug treatments using real world data: emulation of a target trial.
    Deng Y; Polley EC; Wallach JD; Herrin J; Ross JS; McCoy RG
    BMJ Med; 2023; 2(1):e000419. PubMed ID: 37577025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Effects of Liraglutide in a Real-World Setting in Spain: eDiabetes-Monitor SEEN Diabetes Mellitus Working Group Study.
    Mezquita-Raya P; Reyes-Garcia R; Moreno-Perez O; Escalada-San Martin J; Ángel Rubio Herrera M; Lopez de la Torre Casares M
    Diabetes Ther; 2015 Jun; 6(2):173-85. PubMed ID: 26055216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interindividual differences in the clinical effectiveness of liraglutide in Type 2 diabetes: a real-world retrospective study conducted in Spain.
    Gomez-Peralta F; Lecube A; Fernández-Mariño A; Alonso Troncoso I; Morales C; Morales-Pérez FM; Guler I; Cadarso-Suárez C
    Diabet Med; 2018 Nov; 35(11):1605-1612. PubMed ID: 29943854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improved Glycemic Control Achieved by Switching to Insulin Degludec in Insulin-Treated Patients with Type 2 Diabetes in a Real-World Setting: a Non-interventional, Retrospective Cohort Study.
    Melzer Cohen C; Thorsted BL; Wolden ML; Chodick G; Karasik A
    Diabetes Ther; 2017 Oct; 8(5):1047-1055. PubMed ID: 28884311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis.
    Lorenzi M; Ploug UJ; Langer J; Skovgaard R; Zoratti M; Jansen J
    Diabetes Ther; 2017 Feb; 8(1):85-99. PubMed ID: 27995594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients.
    Fadini GP; Simioni N; Frison V; Dal Pos M; Bettio M; Rocchini P; Avogaro A
    Acta Diabetol; 2013 Dec; 50(6):943-9. PubMed ID: 23754673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of liraglutide in a real-life cohort.
    Heymann A; Maor Y; Goldstein I; Todorova L; Schertz-Sternberg P; Karasik A
    Diabetes Ther; 2014 Jun; 5(1):193-206. PubMed ID: 24664620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
    Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
    JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A retrospective audit of type 2 diabetes patients prescribed liraglutide in real-life clinical practice.
    Mulligan CM; Harper R; Harding J; McIlwaine W; Petruckevitch A; McLaughlin DM
    Diabetes Ther; 2013 Jun; 4(1):147-51. PubMed ID: 23715814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liraglutide effect and action in diabetes-In (LEAD-In): A prospective observational study assessing safety and effectiveness of liraglutide in patients with type 2 diabetes mellitus treated under routine clinical practice conditions in India.
    Wangnoo SK; Kumar S; Bhattacharyya A; Tripathi S; Akhtar S; Shetty R; Ghosal S
    Indian J Endocrinol Metab; 2016; 20(6):838-845. PubMed ID: 27867889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liraglutide - Indian Experience.
    Anirban M; Soumyabrata RC; Debmalya S; Bhattacharjee K
    Indian J Endocrinol Metab; 2018; 22(6):818-826. PubMed ID: 30766825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liraglutide Effectiveness in Type 2 Diabetes: Insights from a Real-World Cohort of Portuguese Patients.
    Silva-Nunes J; Nascimento E; Louro J; Dores J; Laginha T; Gonçalves-Ferreira A; Alves M; Souto SB; Cunha N; Pina E; Duarte R; Raposo JF
    Metabolites; 2022 Nov; 12(11):. PubMed ID: 36422260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The incidence of retinopathy in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness study (GRADE).
    Hsia DS; Younes N; Krause-Steinrauf H; Kassem LS;
    J Diabetes Complications; 2024 Mar; 38(3):108692. PubMed ID: 38354481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of Liraglutide in Type II Diabetes Mellitus Management: Experience in Emirati Patients.
    Ghuman NK; Saadah LM; Al Najjar MS; Shaheen DY; Am SI; Al Ali MM
    Clin Med Insights Endocrinol Diabetes; 2015; 8():67-72. PubMed ID: 26441485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and psychological characteristics of liraglutide treatment among patients with type 2 diabetes.
    Al Hayek AA; Al Dawish MA
    J Family Med Prim Care; 2020 Feb; 9(2):1065-1071. PubMed ID: 32318468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 6-month sitagliptin treatment on metabolic parameters in diabetic patients taking oral glucocorticoids: a retrospective cohort study.
    Katsuyama H; Sako A; Adachi H; Hamasaki H; Yanai H
    J Clin Med Res; 2015 Jun; 7(6):479-84. PubMed ID: 25883713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sitagliptin: Is It Effective in Routine Clinical Practice?
    Mohan Dallumal R; Chua SS; Wu DB; Vethakkan SR
    Int J Endocrinol; 2015; 2015():950571. PubMed ID: 26089904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.